Post-acute Sequelae of Sars-cov-2 Infection
📧 Sign up to get email alerts when something new happens for Post-acute Sequelae of Sars-cov-2 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS [NA]
This is a clinical trial update about ear-based vagus nerve stimulation for Post-COVID-19 symptoms (Long COVID) and myalgic encephalomyeliti…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome. [NA]
A clinical trial evaluating Endourage Formula C™ Oral Drops for post-acute COVID-19 syndrome has completed.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center? [NA]
The study evaluates a technology-enabled, multidisciplinary team-based care model for managing long COVID and related fatiguing illnesses wi…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Evaluation of the Effectiveness of Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital [NA]
This clinical trial entry describes a prospective study at Reunion University Hospital evaluating whether a breathing control technique can …
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Cognitive Rehabilitation Therapy for COVID-19 [NA]
This update describes an ongoing clinical trial evaluating cognitive rehabilitation therapy for Post-Acute COVID-19 Syndrome, sponsored by t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study) [Phase 2]
Pilot Phase 2 study evaluating bevacizumab for dyspnea in post-acute sequelae of SARS-CoV-2 infection (long COVID); the trial status is not …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: AT1001 for the Treatment of Long COVID [Phase 2]
AT1001 is being evaluated in a Phase 2 trial for Long COVID and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) [Phase 2]
Protocol update for the RECOVER-AUTONOMIC Phase 2 trial detailing IVIG use in long COVID.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
This clinical trial update indicates ongoing recruitment for a study investigating ventilatory and perfusion abnormalities in individuals wi…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Microbial and Cytokine Signatures in Long COVID Patients
An ongoing clinical trial is enrolling by invitation to investigate microbial and cytokine signatures in patients with post-acute sequelae o…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19 [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate low-dose sirolimus for post-acute sequelae of SARS-CoV-2 infection (Long COVID). The stud…
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID [NA]
A double-blind randomized placebo-controlled trial of a proprietary full hemp flower formulation for post-acute COVID-19 syndrome has been w…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis [NA]
The study is a randomized controlled trial evaluating mind-body interventions for Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue S…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation [Phase 2]
Phase 2 clinical trial assessing magnetic resonance analysis of neural inflammatory factors and external stimulation for Long COVID; current…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Nutritional Management of Post COVID-19 Cognitive Symptoms [NA]
A clinical trial update shows recruitment ongoing for a study on nutritional management to address cognitive symptoms following SARS-CoV-2 i…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Effects os Physiotherapeutic Rehabilitation on Function Autonomic and Inflammatory in Patients With Long Covid [NA]
This entry describes an ongoing clinical trial evaluating the effects of physiotherapeutic rehabilitation on autonomic function and inflamma…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation [NA]
A clinical trial evaluating whether behavioral strategies to reduce adiposity can improve rehabilitation outcomes in people with Post-COVID …
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 [Phase 4]
A Phase 4 clinical trial evaluating Niagen (nicotinamide riboside) for recovery from persistent cognitive and physical symptoms after COVID-…
-
CLINICAL_TRIALS research · 2025-06-16Clinical Trial Update: Comprehensive Imaging Exam of Convalesced COVID-19 Patients [NA]
This clinical trial update notes a Johns Hopkins study evaluating comprehensive imaging in convalescent COVID-19 patients, currently enrolli…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment [Phase 1]
A Phase 1 clinical trial assessing the Vielight Neuro RX Gamma device for post-COVID-19 cognitive impairment has completed.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Attention, Memory and Quality of Life in Post-COVID-19 Adults [NA]
A clinical trial studying attention, memory, and quality of life in adults with post-acute sequelae of SARS-CoV-2 infection (long COVID/brai…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Cellular Senescence and COVID-19 Long-Hauler Syndrome
Mayo Clinic is conducting a clinical trial on cellular senescence and long-hauler COVID-19 (SARS-CoV-2 infection); the study (NCT04903132) i…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Effects of Auricular Vagus Nerve Stimulation Combined With Slow-paced Breathing on Individuals With Postural Orthostatic Tachycardia Syndrome. [NA]
This clinical trial update describes a study evaluating auricular vagus nerve stimulation combined with slow-paced breathing in people with …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
This document provides an update on a clinical trial evaluating quality of life after hyperbaric oxygen therapy in patients with long COVID.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.